Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: UNIVERSITY OF ALABAMA AT BIRMINGHAM
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2017-08-31 to 2024-02-28
Current total value of award: $3196306.96
Description: A PHASE III COMPARATIVE TRIAL OF BENZATHINE PENICILLIN G, 2.4 MILLION UNITS ADMINISTERED AS A SINGLE DOSE VERSUS THREE SUCCESSIVE WEEKLY DOSES FOR TREATMENT OF EARLY SYPHILIS IN PERSONS WITH AND WITHOUT HIV.